A MRD‐GUIDED APPROACH FOR THE COMBINATION OF IBRUTINIB TO VENETOCLAX IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (IMPROVE STUDY). (June 2017) - Ghia, P.; Scarfò, L.; Coscia, M.; Sancetta, R.; Ferrario, A.; Tedeschi, A.; Farina, L.; Laurenti, L.; Orlandi, E.; Reda, G.; Motta, M.; Carlo Stella, C.; et al.